Loading company…
Synageva BioPharma develops therapies for rare genetic diseases.
Founded in 1996, Synageva BioPharma is based in Lexington, US, and develops therapies for rare genetic conditions. It raised USD 25.00 mn in funding as of March 2011, with backing from Baker Brothers Investments, Hunt BioVentures, New Leaf Venture Partners and Yasuda Enterprise Development. In 2014, the company reported revenue of USD 6,492,000 and EBITDA of USD -182,264,000.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in